NDC Package 71731-5111-1 Fosaprepitant

Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71731-5111-1
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Fosaprepitant
Non-Proprietary Name:
Fosaprepitant Dimeglumine
Substance Name:
Fosaprepitant Dimeglumine
Usage Information:
Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
11-Digit NDC Billing Format:
71731511101
NDC to RxNorm Crosswalk:
  • RxCUI: 1731077 - fosaprepitant 150 MG Injection
  • RxCUI: 1731077 - fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    ANDA212143
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-16-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71731-5111-1?

    The NDC Packaged Code 71731-5111-1 is assigned to a package of 1 vial, single-dose in 1 carton / 5 ml in 1 vial, single-dose of Fosaprepitant, a human prescription drug labeled by Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.

    Is NDC 71731-5111 included in the NDC Directory?

    Yes, Fosaprepitant with product code 71731-5111 is active and included in the NDC Directory. The product was first marketed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. on March 16, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71731-5111-1?

    The 11-digit format is 71731511101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-171731-5111-15-4-271731-5111-01